Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease

Clinical and Experimental Rheumatology

Volumn 27, Issue 2 SUPPL.53, 2009, Pages

  Boiardi, Luigi ^a   Atzeni, Fabiola ⁱ   Casali, Bruno ^a   Farnetti, Enrico ^a   Nicoli, Davide ^a   Pipitone, Nicolò ^a   Catanoso, Maria Gracia ^a   Olivieri, Ignacio ^b   Cantini, Fabrizio ^c   Salvi, Fabrizio ^d   La Corte, Renato ^e   Triolo, Giovanni ^f   Filippini, Davide ^g   Paolazzi, Giuseppe ^h   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b SAN CARLO HOSPITAL   (Italy)

^c MISERICORDIA E DOLCE HOSPITAL   (Italy)

^d BELLARIA HOSPITAL   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h Ospedale Santa Chiara   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

Author keywords

Beh et's disease; Clinical manifestations; Italian patients; Severity score; TLR4 polymorphisms; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70350146351     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. YURDAKUL S, YAZICI H: Behçet's syndrome. Best Pract Res Clin Rheumatol 2008; 22: 793-809.
2. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-1291
3. SALVARANI C, BOIARDI L, MANTOVANI V et al.: Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease. J Rheumatol 2001; 28: 1867-1870 (Pubitemid 32726936)
4. BOIARDI L, SALVARANI C, CASALI B et al.: Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease. J Rheumatol 2001; 28: 1283-1287 (Pubitemid 32510499)
5. SALVARANI C, BOIARDI L, CASALI B et al.: Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol 2004; 31: 1785-1789 (Pubitemid 39202522)
6. SALVARANI C, BOIARDI L, CASALI B et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 2002; 29: 535-540 (Pubitemid 34202824)
7. KOBAYASHI M, ITO M, NAKAGAWA A et al.: Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology 2000; 36: 362-371
8. TUZUN B, TUZUN Y, YURDAKUL S et al.: Neutrophil chemotaxis in Behçet's syndrome. Ann Rheum Dis 1999; 58: 658.
9. NIWA Y, MIYAKE S, SAKANE T, SHINGU M, YOKOYAMA M: Auto-oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982; 49: 247-255
10. NIWA Y, MIZUSHIMA Y: Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from Streptococcus-stimulated lymphocytes of patients with Behçet's disease. Clin Exp Immunol 1990; 79: 353-360
11. PRONAI L, ICHIKAWA Y, NAKAZAWA H, ARIMORI S: Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease-effects of Ichicines. Clin Exp Rheumatol 1991; 9: 227-233
12. MEGE JL, DILSEN N, SANGUEDOLCE V et al.: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544-1549
13. DOGAN P, TANRIKULU G, SOYUER U, KOSE K: Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease. Clin Biochem 1994; 27: 413-418
14. TRIOLO G, ACCARDO-PALUMBO A, TRIOLO G, CARBONE MC, FERRANTE A, GIARDINA E: Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 1999; 91: 330-337
15. ACCARDO-PALUMBO A, TRIOLO G, CARBONE MC et al.: Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol 2000; 18: 495-498 (Pubitemid 30616946)
16. ARBOUR NC, LORENZ E, SCHUTTE BC et al.: DA.TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191
17. BROWNING BL, HUEBNER C, PETERMANN I et al.: Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007; 102: 2504-2512
18. SNELGROVE T, LIM S, GREENWOOD C et al.: Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 2007; 34: 368-370
19. ADAM R, STURROCK RD, GRACIE JA: TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann Rheum Dis 2006; 65: 1099-1101
20. LAMB R, ZEGGINI E, THOMSON W, DONN R: Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Ann Rheum Dis 2005; 64: 767-769 (Pubitemid 40559307)
21. RADSTAKE TR, FRANKE B, HANSSEN S et al.: The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004; 50: 999-1001.
22. SÁNCHEZ E, OROZCO G, LÓPEZ-NEVOT MA, JIMÉNEZ-ALONSO J, MARTÍN J: Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54-57
23. PABST S, BAUMGARTEN G, STREMMEL A et al.: Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143: 420-426
24. REINDL M, LUTTEROTTI A, INGRAM J et al.: Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003; 61: 85-88 (Pubitemid 36286753)
25. SCHRÖDER NW, SCHUMANN RR: Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164
26. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-1080
27. KRAUSE I, MADER R, SULKES J et al.: Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-1036
28. SAMBROOK, J, FRITSCH EF, MANIATIS T: In: NOLAN C (Ed.) Molecular Cloning. A laboratory manual. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 1989; p.9-17.
29. LORENZ E, SCHWARTZ DA, MARTIN PJ et al.: Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 384-387
30. ROELOFS MF, ABDOLLAHI-ROODSAZ S, JOOSTEN LA, VAN DEN BERG WB, RADSTAKE TR: The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 2008; 58: 338-348
31. DIRESKENELI H, SARUHAN-DIRESKENELI G: The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S44-8.
32. BIRTAS-ATESOGLU E, INANC N, YAVUZ S, ERGUN T, DIRESKENELI H: Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behçet's disease. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S96-8.
33. SAHIN S, LAWRENCE R, DIRESKENELI H, HAMURYUDAN V, YAZICI H, AKOǦLU T: Monocyte activity in Behçet's disease. Br J Rheumatol 1996; 35: 424-429
34. DO JE, KWON SY, PARK S, LEE ES: Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology (Oxford). 2008; 47: 840-848 (Pubitemid 351796370)
35. NARA K, KUROKAWA MS, CHIBA S et al.: Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol 2008; 152: 245-251
36. KIRINO Y, TAKENO M, WATANABE R et al.: Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease. Arthritis Res Ther 2008; 10: R16.
37. NA KS, KIM TH, RAHMAN P, PEDDLE L, CHOI CB, INMAN RD: Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol Int 2008; 28: 627-630
38. VAN DER PAARDT M, CRUSIUS JB, DE KONING MH et al.: No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis 2005; 64: 235-238
39. GERGELY P JR, BLAZSEK A, WEISZHÁR Z, PAZÁR B, POÓR G: Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population. Rheumatology (Oxford). 2006; 45: 1194-1196
40. KILDING R, AKIL M, TILL S et al.: A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 340-342
41. BOIARDI L, CASALI B, FARNETTI E et al.: Toll like receptors 4 (TLR4) gene polymorphism in giant cell arteritis. Clin Exp Rheumatol 2009; 27 (Suppl. 53): xx-xx.
42. HONG J, LEUNG E, FRASER AG, MERRIMAN TR, VISHNU P, KRISSANSEN GW: TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol 2007; 22: 1760-1766 (Pubitemid 47525075)
43. MINORETTI P, GAZZARUSO C, VITO CD et al.: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett 2006; 391: 147-149
44. MEGURO A, OTA M, KATSUYAMA Y et al.: Association of the toll-like receptor 4 gene polymorphisms with Behćet's disease. Ann Rheum Dis 2008; 67: 725-727 (Pubitemid 351571945)
45. BACANLI A, SALLAKCI N, YAVUZER U, ALPSOY E, YEGIN O: Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behćet's disease. Clin Exp Dermatol 2006; 31: 699-701. (Pubitemid 44086803)
46. TOMIYAMA R, MEGURO A, OTA M et al.: Investigation of the association between Toll-like receptor 2 gene polymorphisms and Behćet's disease in Japanese patients. Hum Immunol 2009; 70: 41-44
47. ITO A, OTA M, KATSUYAMA Y, INOKO H, OHNO S, MIZUKI N: Lack of association of Toll-like receptor 9 gene polymorphism with Behćet's disease in Japanese patients. Tissue Antigens 2007; 70: 423-426 (Pubitemid 47537403)